The present invention provides novel heteroaryl compounds and analogues
thereof, which are selective inhibitors of the human P2Y.sub.1 receptor.
The invention also provides for various pharmaceutical compositions of
the same and methods for treating diseases responsive to modulation of
P2Y.sub.1 receptor activity.